ID

39095

Descripción

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01869764

Link

https://clinicaltrials.gov/show/NCT01869764

Palabras clave

Versiones (1)
  1. 1/12/19 1/12/19 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

1 de diciembre de 2019

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Ductal Breast Carcinoma in Situ NCT01869764

Inglés

Eligibility Ductal Breast Carcinoma in Situ NCT01869764

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
newly diagnosed stage i to iii breast cancer and carcinoma in situ (including lobular carcinoma in situ [lcis] and ductal carcinoma in situ [dcis])
Descripción

Breast Carcinoma TNM Breast tumor staging | Carcinoma in Situ TNM Breast tumor staging | LCIS TNM Breast tumor staging | DCIS TNM Breast tumor staging

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0678222
UMLS CUI [1,2]
C0474926
UMLS CUI [2,1]
C0007099
UMLS CUI [2,2]
C0474926
UMLS CUI [3,1]
C0279563
UMLS CUI [3,2]
C0474926
UMLS CUI [4,1]
C0007124
UMLS CUI [4,2]
C0474926
breast surgery (lumpectomy or mastectomy) is planned for at least 7 days from the day of enrollment
Descripción

Operation on breast Planned | Segmental Mastectomy Planned | Mastectomy Planned

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3714726
UMLS CUI [1,2]
C1301732
UMLS CUI [2,1]
C0024885
UMLS CUI [2,2]
C1301732
UMLS CUI [3,1]
C0024881
UMLS CUI [3,2]
C1301732
ability to understand and the willingness to sign an institutional review board (irb)-approved written informed consent document
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
tumor measures at least 1 centimeter on imaging or physical exam
Descripción

Tumor size Imaging | Tumor size Physical Examination

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0475440
UMLS CUI [1,2]
C0011923
UMLS CUI [2,1]
C0475440
UMLS CUI [2,2]
C0031809
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
any patient with surgery scheduled < 7days after biopsy
Descripción

Patient scheduled for surgery | Status post Biopsy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C3242215
UMLS CUI [2,1]
C0231290
UMLS CUI [2,2]
C0005558
patients who are unable to refrain from the use of any nsaid or full-dose acetylsalicylic acid (asa)-containing nsaid while taking study drug
Descripción

Discontinue NSAIDs Unable | Discontinue Aspirin Unable

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1444662
UMLS CUI [1,2]
C0003211
UMLS CUI [1,3]
C1299582
UMLS CUI [2,1]
C1444662
UMLS CUI [2,2]
C0004057
UMLS CUI [2,3]
C1299582
patients who will receive neoadjuvant chemotherapy are not eligible
Descripción

Neoadjuvant Chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0600558
UMLS CUI [1,2]
C3665472
patients who are currently taking omega-3 fatty acids, as they are unable to be randomized to placebo
Descripción

Omega-3 Fatty Acids

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0015689
patients who have previously taken omega-3 fatty acid within 1 month prior to study enrollment
Descripción

Omega-3 Fatty Acids Previous

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0015689
UMLS CUI [1,2]
C0205156
patients with an allergy or known hypersensitivity to fish
Descripción

Allergy to fish

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0856904
Volver a la parte superior de la página

Similar models

Eligibility Ductal Breast Carcinoma in Situ NCT01869764

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Breast Carcinoma TNM Breast tumor staging | Carcinoma in Situ TNM Breast tumor staging | LCIS TNM Breast tumor staging | DCIS TNM Breast tumor staging
Item
newly diagnosed stage i to iii breast cancer and carcinoma in situ (including lobular carcinoma in situ [lcis] and ductal carcinoma in situ [dcis])
boolean
C0678222 (UMLS CUI [1,1])
C0474926 (UMLS CUI [1,2])
C0007099 (UMLS CUI [2,1])
C0474926 (UMLS CUI [2,2])
C0279563 (UMLS CUI [3,1])
C0474926 (UMLS CUI [3,2])
C0007124 (UMLS CUI [4,1])
C0474926 (UMLS CUI [4,2])
Operation on breast Planned | Segmental Mastectomy Planned | Mastectomy Planned
Item
breast surgery (lumpectomy or mastectomy) is planned for at least 7 days from the day of enrollment
boolean
C3714726 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])
C0024885 (UMLS CUI [2,1])
C1301732 (UMLS CUI [2,2])
C0024881 (UMLS CUI [3,1])
C1301732 (UMLS CUI [3,2])
Informed Consent
Item
ability to understand and the willingness to sign an institutional review board (irb)-approved written informed consent document
boolean
C0021430 (UMLS CUI [1])
Tumor size Imaging | Tumor size Physical Examination
Item
tumor measures at least 1 centimeter on imaging or physical exam
boolean
C0475440 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
C0475440 (UMLS CUI [2,1])
C0031809 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Patient scheduled for surgery | Status post Biopsy
Item
any patient with surgery scheduled < 7days after biopsy
boolean
C3242215 (UMLS CUI [1])
C0231290 (UMLS CUI [2,1])
C0005558 (UMLS CUI [2,2])
Discontinue NSAIDs Unable | Discontinue Aspirin Unable
Item
patients who are unable to refrain from the use of any nsaid or full-dose acetylsalicylic acid (asa)-containing nsaid while taking study drug
boolean
C1444662 (UMLS CUI [1,1])
C0003211 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C1444662 (UMLS CUI [2,1])
C0004057 (UMLS CUI [2,2])
C1299582 (UMLS CUI [2,3])
Neoadjuvant Chemotherapy
Item
patients who will receive neoadjuvant chemotherapy are not eligible
boolean
C0600558 (UMLS CUI [1,1])
C3665472 (UMLS CUI [1,2])
Omega-3 Fatty Acids
Item
patients who are currently taking omega-3 fatty acids, as they are unable to be randomized to placebo
boolean
C0015689 (UMLS CUI [1])
Omega-3 Fatty Acids Previous
Item
patients who have previously taken omega-3 fatty acid within 1 month prior to study enrollment
boolean
C0015689 (UMLS CUI [1,1])
C0205156 (UMLS CUI [1,2])
Allergy to fish
Item
patients with an allergy or known hypersensitivity to fish
boolean
C0856904 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial